Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
Go back to Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results| (NASDAQ: NAGE) | Delayed: 2.68 -0.11 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.79 | 52 Week High | $ | |||
| Open | $2.79 | 52 Week Low | $ | |||
| Day High | $2.79 | P/E | N/A | |||
| Day Low | $2.67 | EPS | $ | |||
| Volume | 865,143 | |||||



